Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Get an introduction to all features of this page

Mirum Pharmaceuticals Inc. Stock

Price
Target price
€38.00

€38.00

1.580%
0.6
1.580%
€41.00
 
11.09.24 / Tradegate WKN: A2PM29 / Name: Mirum Pharmaceuticals Inc. / Stock / ? /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Mirum Pharmaceuticals Inc. in the next few years
Wizard

Mirum Pharmaceuticals Inc. Stock

There is an upward development for Mirum Pharmaceuticals Inc. compared to yesterday, with an increase of €0.60 (1.580%).
With 0 Sell predictions and 2 Buy predictions the community sentiment towards the Mirum Pharmaceuticals Inc. stock is not clear.
As a result the target price of 41 € shows a slightly positive potential of 7.89% compared to the current price of 38.0 € for Mirum Pharmaceuticals Inc..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Mirum Pharmaceuticals Inc. stock. Negative votes have not been in the majority for any criteria for this stock
What does Mirum Pharmaceuticals Inc. do?

Pros and Cons of Mirum Pharmaceuticals Inc. in the next few years

Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

Analyzing the financials of Mirum Pharmaceuticals Inc. presents a revealing portrait of a company navigating a complex landscape. With a market capitalization of approximately $1.75 billion, Mirum holds a significant position within the pharmaceutical sector. However, it faces several challenges, as reflected in its financial ratios and performance metrics. The company's negative EBITDA and profit margins indicate it is currently operating at a loss, suggesting critical areas for improvement but also showcasing potential for growth if strategies effectively pivot toward profitability.

Market Presence and Valuation: A market capitalization of around $1.75 billion indicates investor confidence in the company’s potential, especially within a dynamic industry like pharmaceuticals. This metric often reflects future growth potential, highlighting positive market sentiment.

Revenue Generation: Mirum reported a trailing twelve-month (TTM) revenue of approximately $224 million. This suggests that the company is capable of generating significant income, which, although not currently profitable, can be reinvested for growth or used to stabilize operations.

Show more
Register To Post